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Background: Cysteine proteases of the liver fluke, Fasciola hepatica, participate in catabolism of proteins, migration of the 
fluke through host tissues and combat host immune system.
Objectives: In this study, we evaluated proteolytic activity of F. hepatica recombinant cathepsin L1 (rCL1) against gelatin 
and collagen as common substrates.
Material and Methods: The coding sequences of F. hepatica CL1 were cloned and expressed in Escherichia coli, in our 
previous study. The rCL1 was purified by nickel affinity chromatography with a HisTrap Column. The protein concentrations 
of the purified fractions were determined by Bradford assay. Rat collagen type-1 was treated with distinct amounts of rCL1 at 
37 °C, overnight, and the byproduct was analyzed by SDS-PAGE. Furthermore, we used bovine skin gelatin as zymography 
substrate to evaluate the gelatinolytic activity of the purified rCL1. 
Results: Recombinant CL1 was capable to digest intact type-1 collagen within 24 h and the gelatinlytic activity of rCL1 was 
visible at approximately 37 kDa region, with optimal activity at acidified conditions (pH 4).
Conclusion: Findings provide a possible mechanism by which a major secretory molecule of F. hepatica could be involved 
in parasite survival as well as its pathogenesis. 
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1. Background 
Fasciolosis is a zoonotic disease commonly transmitted by 
metacercariae-infected herbs or vegetables. Fasciola (F) 
hepatica and F. gigantica may infect both livestock and 
humans and has recently emerged as a serious pathogen (1).
Recently proteomic analyses of F. hepatica life stages 
have provided valuable information on the expression 
of key proteases which are potentially involved in host-
parasite interactions (2,3). The findings showed that 
cysteine proteases play a major role in these interactions 
and cathepsin L (CL) family which is composed of five 
distinct clades (FhCL1, FhCL2, FhCL3, FhCL4 , and 
FhCL5) is the most important one. These virulence-
associated cysteine proteases show a firm temporal 
regulation in their expression levels during the 
parasite’s development in the mammalian host (2). For 
example, FhCL3 is highly expressed in newly excysted 
juvenile Fasciola that initiate the infection, but once 
the juvenile Fasciola travel across the intestinal wall, 
the expression of FhCL3 is down-regulated (2,3). As 
the parasite migrates through the liver parenchyma and 
becomes adult within the bile ducts, the expression of 
FhCL1, FhCL2, and FhCL5 is up-regulated (2,3).
 Cathepsin L1 (CL1) is a major excretory cysteine 
protease which is commonly produced by the parasite 
and participates in the catabolism of proteins, migration 
of the fluke through the host intestine and penetration 
of the parasite to the Glisson’s capsule of the liver 
through the cleaving of interstitial matrix proteins 
such as fibronectin, laminin, and native collagens 
of the host tissues. It also provides mechanisms for 
combating with host immune system, thus playing 
an essential role in the pathogenicity of the parasite. 
Additionally, it has recently been revealed that 
CL1 may suppress Th1 immune responses in laboratory 
animals and dispose them to simultaneous bacterial co-
infections (4, 5). Therefore, this protease could be a 
target of intervention strategies. 
The crucial role of F. hepatica cysteine proteases, 
specially cathepsins in the pathogenesis of this parasite, 
including the invasion of tissues, acquisition of nutrients, 
and immunomodulation has made them key targets for 
the development of novel vaccines and drugs (6). 
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2. Objectives
 In this study, we evaluated the proteolytic activity of a 
previously produced F. hepatica recombinant CL1 against 
gelatin and collagen as common protein substrates, to 
confirm the functionality of the produced enzyme.
3. Materials and Methods
3.1. Cathepsin L1 Source
The coding sequence of F. hepatica CL1 (Gen Bank 
accession No. U62288.2) was previously cloned in 
pET-21 and the recombinant protein was expressed in 
Escherichia coli BL21 (DE3) cells; the product was then 
purified using HisTrap nickel affinity chromatography 
column (7). In this study, following a re-expression 
and purification steps, the quantity and quality of the 
purified fractions were determined by SDS-PAGE and 
Bradford assay, respectively. 
Moreover, livers from F. hepatica-infected sheep were 
collected from the Kahrizak slaughterhouse (Tehran, Iran) 
and the adult flukes were collected and washed with sterile 
phosphate-buffered saline (PBS). Then, the live flukes were 
incubated in RPMI medium (1 fluke per 2 mL of medium; 
Gibco-BRL, Gaithersburg, MD, USA), containing 100 
IU.mL-1 of penicillin, 100 μg.mL-1 of streptomycin and 
sufficient amounts of anti-protease cocktail at 37 °C, 
overnight in a humidified CO2 incubator as previously 
described (7). Then, the excretory-secretory (E/S) product 
of the parasites was collected and centrifuged at 10,000 x g 
for 30 min at 4 °C. 
3.2. Purification of rCL1 by FPLC Method
The rCL1 was also purified by anion exchange 
chromatography using AKTA PRIM plus Fast Protein 
Liquid Chromatography (FPLC) system (GE healthcare 
Biosciences, Uppsala, Sweden). Briefly, DEAE-
Sepharose 6B resin was equilibrated with 20 mM Tris-
HCl pH 8.0 as the starting buffer. The bacterial lysate 
(rCL1 expressing E. coli BL21) was dialyzed against the 
starting buffer and loaded on the column. The contents 
were fractionated using the starting buffer supplied by 
increasing gradient amounts of sodium chloride as 
elution buffer. Similar peaks from several runs were 
pooled and concentrated by lyophilization. The contents 
of the fractions were analyzed by subjecting to 12% SDS-
PAGE slabs in parallel to molecular weight standards. 
3.3. Collagenase Activity 
The collagenolytic activity of the rCL1 was initially 
checked by directly mixing the purified rCL1 with 
a commercial collagen. In brief, rat type-1 collagen 
(Calbiochem, UK) was dissolved to a final concentration 
of 1 μg.mL-1, then 15 µg of the collagen was mixed 
with 0.5 µg of the purified rCL1 or acetate buffer (as 
control), and the contents were incubated for 24 h at 37 
°C. Finally, digestion of the collagen was analyzed on 
12% SDS-PAGE (8). 
3.4. Gelatin Zymography
Gelatin zymography or gelatin substrate polyacrylamide 
gel electrophoresis was used for the evaluation of the 
gelatinolytic activity of the rCL1 and the E/S components 
of F. hepatica as its initial native source. Resolving 
gel (12%) containing 0.3% gelatin was prepared as 
previously described (9, 10). Recombinant CL1 and 
E/S were mixed with non-reducing sample buffer and 
appropriate volumes of the prepared sample were loaded 
onto the gel without heating. Following electrophoresis, 
the slab was washed for a total of an hour in 2.5% Triton 
X-100, prepared in 0.1 M sodium phosphate pH 6.0, to 
remove SDS. The slab was then incubated overnight at 
37 °C in the activation buffer (0.1 M sodium phosphate 
pH 6.0) and stained with Coomassie Brilliant blue 
R-250. After de-staining, the gels were scanned and the 
proteolysis areas were analyzed by densitometry. 
4. Results
4.1. Purification of rCL1 by Anion Exchange 
Chromatography Using FPLC 
One typical protein peak was observed following 
the purification of the recombinant protein by anion 
exchange chromatography of F. hepatica rCL1 (Fig. 1A) 
or affinity chromatography method. The fractions 
corresponding to identical peaks were collected. Silver 
nitrate staining of the SDS-PAGE showed a single band 
with an apparent 37 kDa size (Fig. 1B).
4.2. Collagen Activity 
Evaluation of collagenase activity showed that the 
purified recombinant enzyme was capable to completely 
digest the intact rat type 1 collagen alpha chains within 
24 h incubation at 37 °C, while the addition of PBS in 
the negative control did not result in any alteration in 
the contents of the substrate (Fig. 2A). 
4.3. Gelatin Zymography: For Gelatinolytic Analysis 
We Used Gelatin Substrate. 
Recombinant and native products were run on the 
zymography gel and following an overnight activation 
step, the enzyme gelatinolytic activity was visualized on 
de-stained gels. Under non-reducing conditions, rCLI was 
capable to degrade gelatin and produce a distinct unstained 
region at 37 kDa (Fig. 2B), while, E/S could digest gelatin 
in different regions, resulting a smear (Fig. 2C). 
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Fig 1. Anion exchange chromatography of F. hepatica rCL1. A: FPLC chromatogram of F. hepatica rCL1 obtained by anion exchange 
chromatography on a DEAE Sepharose CL-6B column. A typical peak was obtained when the NaCl in the elution buffer exceeded 40-50%. 
B: Fraction was electrophoresed on 12% polyacrylamide gels and visualized by silver nitrate staining. 
Fig 2. Proteolytic activity of Fasciola hepatica recombinant cathepsin L1 (rCL1) and E/S. A: Collagenase activity of rCL1 Similar 
amounts of rat type 1 collagen was mixed with PBS (Lane 1), or rCL1 (lane 2) and incubated for 24 h at 37°C. The products were run on 
SDS-PAGE and stained with Coomassie blue G250. B: Gelatine zymography of rCL1 SDS-PAGE gel was incorporated with gelatin, then 
F. hepatica rCL1 or excretory/secretory products were run without heating (native electrophoresis). The rCL1 digested gelatin substrate at 37 
kDa region. C: Gelatine zymography of E/S Excretory/secretory product digested the gelatin in different regions and resulted various bands. 
4. Discussion
Cathepsin L1 is a secretory product of F. hepatica and is a 
major protease found in excretory-secretory metabolites 
of this fluke, which is potentially harmful for humans 
or sheep (11). It facilitates penetration and migration 
of fasciola in host tissues such as liver and intestine, 
and plays a crucial role in the survival of living flukes in 
physiologic conditions. In this regard, we analyzed the 
proteolytic impact of this enzyme on two substrates, 
namely collagen and gelatin (12). In accordance with 
the findings of Corvo (13), Howell (14) and some other 
researchers (15, 16), our study showed that rCl 1 could 
degrade collagen after 24 h incubation and was able to 
digest α1 and α2 chains of collagen.
Collagenase activity of F. hepatica CL1 goes back to 
its catalytic activity on P2 position of collagen which 
is a proline and leucine rich sequence. This function is 
similar to the collagenase activity of human cathepsin K 
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and cathepsin LS on type II collagen (derived from 
bovine nasal septum) and type VI collagen (derived 
from basement membranes). Therefore, F.hepatica 
can damage host tissues and facilitate migration of the 
parasite through liver, bile duct, and other organs. 
Cathepsin F was discovered in other trematodes like 
Paragonimus westermani and Clonorchis sinensis, too 
(15), and serve similar functions such as simplification 
of migration through the host tissue and achievement 
of nutrients by the hydrolysis of hemoglobin 
and collagens (17, 18). In Schistosoma spp., 
both cathepsin L and cathepsin F have been identified (19, 
20) but it is believed that the cathepsin L-like cysteine 
proteases of the Fasciola spp. have significant effects 
on this parasite pathogenicity, distinct from those of the 
other trematode parasites.
Fasciola CLI may have greater participation in 
pathogenicity and host immunomodulation, e.g., by 
the cleavage of immunoglobulins and suppression of 
Th1 responses (21, 22). This function is specific only 
to the Fasciola cathepsin L family and has not been 
detected in other trematodes.
Gelatinase activity of CL1 was also well observed in 
acidic conditions (pH 6). E/S caused a protein smear 
in zymography gel, while rCL1 produced a single 
reactive band at 37 kDa region in similar conditions, 
which were in line with the findings of Dowd et al 
(23). The main gelatinase activity of CL1 occurs in 
acidified conditions with pH ranging from 4 to 7. In 
this study, zymography was performed at pH 6 and the 
functionality of the target protein was nearly identical 
to that found in Dowd et al study (23).
Gelatin is a non-specific substrate which could 
be decomposed by many proteolytic enzymes 
including serine, cysteine, aspartate and cysteine proteases 
as well as metalloproteases which may be found in E/S 
of F. hepatica. Therefore, in gelatin zymography, the 
presence of any type of proteolysis enzyme may result 
in the digestion of gelatin (15). Notably, we applied 
purified form of a recombinant form of CL1 which 
showed enzyme activity in parallel to its previously 
approved immunogenicity (7).
5. Conclusion
Findings provide a mechanism by which F. 
hepatica synthesizes and secretes fully-activated proteases 
which is essential for Fasciola survival as a parasite. The 
data obtained in this study showed a mechanism 
which may facilitate migration of F. hepatica in host 
tissues and provides evasion mechanism from host 
immune system.  Based on the mentioned pathogenicity 
and considering their well-known immunogenicity, it 
seems that Fasciola cathepsins may be used as vaccine 
candidates in experimental and ruminant hosts to 
determine their protection against liver flukes.
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